BrainStorm Cell Therapeutics
BCLI
#10863
Rank
โ‚ฌ7.54 M
Marketcap
0,68ย โ‚ฌ
Share price
-1.25%
Change (1 day)
32.69%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2026 (TTM): -1,03ย โ‚ฌ

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -1,01ย โ‚ฌ. In 2015 the company made an earnings per share (EPS) of -5,84ย โ‚ฌ an increase over its 2014 EPS that were of -8,83ย โ‚ฌ.

EPS history for BrainStorm Cell Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,03ย โ‚ฌ
2015-5,84ย โ‚ฌ-33.82%
2014-8,83ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
8,09ย โ‚ฌ-899.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6,42ย โ‚ฌ-734.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,47ย โ‚ฌ 242.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-5,92ย โ‚ฌ 484.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
0,87ย โ‚ฌ-185.47%๐Ÿ‡บ๐Ÿ‡ธ USA